NEW YORK (GenomeWeb) – A team led by Harvard Medical School researchers has developed polygenic risk scores that could be used to detect Alzheimer's disease before clinical symptoms appear.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.